文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

循环中性粒细胞Toll样受体2和9表达与危重患者死亡率升高相关

Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients.
PubMed 文献 · Shock · 2020-01-01
一句话结论在非选择性危重患者中,中性粒细胞TLR-2和TLR-9表达第三分位可独立于APACHE II、乳酸、肌酐和降钙素原预测30天死亡率。

该前瞻性观察研究纳入三级医疗中心内科ICU连续收治的215例患者,入院时用流式细胞术检测中性粒细胞和单核细胞TLR-2、TLR-4、TLR-9表达。中位APACHE II评分19分,30天死亡率26%。死亡者中性粒细胞TLR-2(P<0.001)和TLR-9(P<0.05)表达显著高于存活者,而中性粒细胞TLR-4及单核细胞TLR表达与生存无关。中性粒细胞TLR-2(OR 3.8;95%CI 1.4-10.2;P<0.05)和TLR-9(OR 4.0;95%CI 2.0-8.1;P<0.001)第三分位表达分别独立于APACHE II、血清乳酸、血清肌酐和降钙素原预测死亡率。

要点

  • 死亡者中性粒细胞TLR-2表达显著高于存活者(P<0.001),TLR-9表达也显著高于存活者(P<0.05)。
  • 中性粒细胞TLR-2第三分位表达预测30天死亡率:OR 3.8(95%CI 1.4-10.2;P<0.05),独立于APACHE II、乳酸、肌酐和降钙素原。
  • 中性粒细胞TLR-9第三分位表达预测30天死亡率:OR 4.0(95%CI 2.0-8.1;P<0.001),独立于APACHE II、乳酸、肌酐和降钙素原。
  • 中性粒细胞TLR-4表达和单核细胞TLR表达与生存无显著关联。
  • 中性粒细胞TLR-2表达与APACHE II、简化急性生理评分II和脓毒症相关器官衰竭评估评分相关。

适用人群与场景

  • 三级医疗中心内科ICU连续收治的215例非选择性危重患者,入院时采血检测。

研究设计与关键结果

  • 前瞻性观察研究,纳入三级医疗中心内科ICU连续收治的215例患者,入院时用流式细胞术检测中性粒细胞和单核细胞TLR-2、TLR-4、TLR-9表达。
  • 中位APACHE II评分19分,30天死亡率为26%。
  • 死亡者中性粒细胞TLR-2表达显著高于存活者(P<0.001),中性粒细胞TLR-9表达也显著高于存活者(P<0.05)。
  • 中性粒细胞TLR-4表达和单核细胞TLR表达与生存无显著关联。
  • 中性粒细胞TLR-2第三分位表达预测30天死亡率:OR 3.8(95%CI 1.4-10.2;P<0.05),独立于APACHE II、血清乳酸、血清肌酐和降钙素原。
  • 中性粒细胞TLR-9第三分位表达预测30天死亡率:OR 4.0(95%CI 2.0-8.1;P<0.001),独立于APACHE II、血清乳酸、血清肌酐和降钙素原。
  • 中性粒细胞TLR-2表达与APACHE II、简化急性生理评分II和脓毒症相关器官衰竭评估评分相关。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,中性粒细胞TLR-2和TLR-9表达对非选择性危重患者30天死亡率具有预后价值,独立于基线临床特征和实验室值。
  • 作者认为,中性粒细胞经特定TLR依赖途径激活先天免疫系统(可能由细胞损伤和细胞内成分释放引起)可能在危重病病理生理中起重要作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Toll-like receptors (TLRs) play an important role in inflammatory processes in critically ill patients by binding to pathogen-associated molecular patterns and danger-associated molecular patterns (DAMPs). Whether neutrophil or monocyte TLR expression patterns are associated with outcome in critical illness is unknown.

OBJECTIVES: To answer this question, we conducted a prospective, observational study including 215 consecutive patients admitted to a medical ICU at a tertiary care center.

METHODS: Blood was drawn at admission and expression of TLR-2, TLR-4, and TLR-9 on neutrophils and monocytes were analyzed by flow cytometry.

RESULTS: Median Acute Physiology and Chronic Health Evaluation II (APACHE II) score was 19, and 30-day mortality was 26%. TLR-2 expression on neutrophils was associated with APACHE II, Simplified Acute Physiology Score II, and Sepsis-related Organ Failure Assessment score. TLR-2 (P < 0.001) and TLR-9 (P < 0.05) expression on neutrophils was significantly higher in nonsurvivors. In contrast, neutrophil TLR-4 expression and monocyte TLR expression were not associated with survival. Neutrophil TLR-2 (odds ratio 3.8; 95% confidence interval 1.4-10.2; P < 0.05) and TLR-9 (odds ratio 4.0; 95% confidence interval 2.0-8.1; P < 0.001) expression in the third tertile predicted mortality independent from APACHE II, serum lactate, serum creatinine, and procalcitonin, respectively.

CONCLUSION: We provide evidence for prognostic properties of neutrophil TLR-2 and TLR-9 expression regarding 30-day mortality in unselected critically ill patients, independent from baseline clinical characteristics, and laboratory values. These findings suggest that specific TLR-dependent activation of the innate immune system via neutrophils possibly caused by cell damage and release of otherwise intracellular components may play a significant role in the pathophysiology of critical illness.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lenz M, Draxler DF, Zhang C, et al. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients. Shock. 2020. PMID: 31688663. doi:10.1097/SHK.0000000000001467

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。